6th February 2012 – Cambridge-based Oval Medical Technologies Limited (“Oval Medical”) has recently collaborated on the Cambridge Venture Project (CVP), part of the MBA programme at the Judge Business School, University of Cambridge.
Oval Medical has developed a unique autoinjector and syringe technology that will allow patients of different ages and from various therapeutic areas to self inject easily and safely with a minimum of training. Oval Medical wanted to fully understand a particular market landscape and turned to the CVP to help explore any potential opportunities for use of an autoinjector.
A team of five MBA students carried out an extensive assessment on Oval Medical’s chosen niche market providing an analysis of competitors and sales trends. They presented an overall analysis of how best to target global pharmaceutical companies, as well as highlighting any potential risks. The project was successfully concluded and provided valuable input in forming a commercial strategy for the year ahead.